The Covid-19 pandemic has scythed vast sums from joint makers’ Q2 sales. But Medtronic’s summer earnings were better than those for its spring quarter.
Mid- and small-cap medtechs find themselves at the mercy of government responses to the Covid-19 pandemic.
Medtronic has had a poor quarter owing to the pandemic – but Zimmer’s has been even worse.
The orthopaedics sector has seen several sizeable mergers over the past decade. Might it see more?
The UK ortho and woundcare group might yet pounce on Nuvasive.
Smaller medtechs saw impressive share price growth in 2018, but not quite as good as the year before.
Wright's bone filler sales are growing fast, but Medtronic still rules.